VERSE: Very Early Rehabilitation in Speech after Stroke

E-mail Print PDF

Lead PI: Associate Professor Erin Godecke

Status: Recruiting

No. of Patients Currently Recruited: 222                                No. of Patients Required:  246

This 3-arm randomised controlled trial (RCT) aims to determine whether a standardised, intensive aphasia therapy regimen (VERSE) is more effective and cost saving than intensive non-standardised usual care training (UC-Plus) and regular usual care (US) therapy provided at 12 weeks post stroke.

Trial URL:

ANZCTR No: ACTRN12613000776707



Last Updated ( Wednesday, 10 January 2018 12:44 )  

Members Login

ASTN Latest news

Top Views